OTCMKTS:IPSEY - IPSEN S A/S Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding IPSEN S A/S Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $18.17 +0.17 (+0.94 %) (As of 02/21/2020 04:00 PM ET) Add Compare Today's Range$17.88Now: $18.17▼$18.1750-Day Range$17.49MA: $20.09▼$22.9152-Week Range$17.20Now: $18.17▼$35.97Volume938 shsAverage Volume1,900 shsMarket Capitalization$6.09 billionP/E Ratio9.61Dividend Yield1.12%Beta0.52 ProfileAnalyst RatingsAdvanced ChartDividendHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Ipsen SA operates as a pharmaceutical company worldwide. It operates in two segments, Specialty Care and Consumer Healthcare. The company offers drugs in oncology, endocrinology, neurology, gastroenterology, cognitive disorders, and rheumatology areas. Its products include Somatuline, which is an injectable treatment for acromegaly and neuroendocrine tumors; Cabometyx, a tablet formulation of cabozantinib for renal cell carcinoma; Onivyde for metastatic pancreatic cancer; Decapeptyl for the treatment of advanced metastatic prostate cancer, uterine fibroids, precocious puberty, endometriosis, and female sterility; and Dysport for motor disorders and muscular spasticity. Read More… Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Diagnostic substances Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:IPSEY Previous Symbol CUSIPN/A CIKN/A Webhttp://www.ipsen.com/ Phone33-01-58-33-50-00Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E Ratio9.61 Forward P/E Ratio7.87 P/E Growth0.6 Sales & Book Value Annual Sales$3.02 billion Price / Sales2.02 Cash Flow$2.25 per share Price / Cash Flow8.09 Book Value$6.50 per share Price / Book2.80Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees5,700 Outstanding Shares335,180,000Market Cap$6.09 billion Next Earnings DateN/A OptionableNot Optionable Receive IPSEY News and Ratings via Email Sign-up to receive the latest news and ratings for IPSEY and its competitors with MarketBeat's FREE daily newsletter. OTC:IPSEY Rates by TradingView IPSEN S A/S (OTCMKTS:IPSEY) Frequently Asked Questions What is IPSEN S A/S's stock symbol? IPSEN S A/S trades on the OTCMKTS under the ticker symbol "IPSEY." What is the consensus analysts' recommendation for IPSEN S A/S? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IPSEN S A/S in the last year. There are currently 1 sell rating and 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for IPSEN S A/S. Has IPSEN S A/S been receiving favorable news coverage? News coverage about IPSEY stock has been trending negative this week, according to InfoTrie. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. IPSEN S A/S earned a news impact score of -2.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for IPSEN S A/S. Who are some of IPSEN S A/S's key competitors? Some companies that are related to IPSEN S A/S include IDEXX Laboratories (IDXX), Neogen (NEOG), Immunomedics (IMMU), Quidel (QDEL), Myriad Genetics (MYGN), Heska (HSKA), Intellia Therapeutics (NTLA), Lantheus (LNTH), Quotient (QTNT), Oxford Immunotec Global (OXFD), Meridian Bioscience (VIVO), Nymox Pharmaceutical (NYMX), Vermillion (VRML), ImmuCell (ICCC) and Celldex Therapeutics (CLDX). What other stocks do shareholders of IPSEN S A/S own? Based on aggregate information from My MarketBeat watchlists, some companies that other IPSEN S A/S investors own include Aeglea Bio Therapeutics (AGLE), Applied Genetic Technologies (AGTC), Heat Biologics (HTBX), Nektar Therapeutics (NKTR), Reata Pharmaceuticals (RETA), Revance Therapeutics (RVNC), Sesen Bio (SESN), Spirit of Texas Bancshares (STXB), United Therapeutics (UTHR) and AMBEV S A/S (ABEV). Who are IPSEN S A/S's key executives? IPSEN S A/S's management team includes the folowing people: Mr. David D. Meek, CEO & Director (Age 56)Mr. Aymeric Le Chatelier, Exec. VP & CFO (Age 50)Dr. Aidan Murphy, Exec. VP of Technical Operations (Age 53)Dr. Alexandre P. Lebeaut, Exec. VP of R&D and Chief Scientific Officer (Age 62)Ms. Eugenia Litz, VP of Investor Relations How do I buy shares of IPSEN S A/S? Shares of IPSEY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is IPSEN S A/S's stock price today? One share of IPSEY stock can currently be purchased for approximately $18.17. How big of a company is IPSEN S A/S? IPSEN S A/S has a market capitalization of $6.09 billion and generates $3.02 billion in revenue each year. The company earns $-56,790,000.00 in net income (profit) each year or $1.89 on an earnings per share basis. IPSEN S A/S employs 5,700 workers across the globe.View Additional Information About IPSEN S A/S. What is IPSEN S A/S's official website? The official website for IPSEN S A/S is http://www.ipsen.com/. How can I contact IPSEN S A/S? IPSEN S A/S's mailing address is 65 quai Georges Gorse, Boulogne-Billancourt cedex I0, 92650. The company can be reached via phone at 33-01-58-33-50-00 or via email at [email protected] MarketBeat Community Rating for IPSEN S A/S (OTCMKTS IPSEY)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 162 (Vote Outperform)Underperform Votes: 182 (Vote Underperform)Total Votes: 344MarketBeat's community ratings are surveys of what our community members think about IPSEN S A/S and other stocks. Vote "Outperform" if you believe IPSEY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPSEY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/22/2020 by MarketBeat.com StaffFeatured Article: Correction
